Immatics (IMTX)
Develops PRAME-focused cancer therapies with cell therapy and TCR bispecific programs.
$8.62
vs last close−0.25 (−2.82%)
Something off on this page? Send us feedback.
Next report
Nov 17, 26
estimated · in 55 days
EPS estimate
−$0.50
Revenue estimate
$12.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.48−$0.35−$0.66−$0.49−$0.34−$0.50−$0.53Pending
Estimate−$0.33−$0.39−$0.38−$0.44−$0.48−$0.42−$0.48−$0.50
Surprise+245.5%+10.3%−73.7%−11.5%+29.2%−19.0%−10.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$58.2M$20.4M$5.6M$6.1M$22.3M$8.8M$11.9MPending
Estimate$23.7M$13.5M$12.5M$10.7M$11.3M$9.8M$11.9M$12.5M
Surprise+145.6%+50.8%−55.5%−43.3%+98.2%−10.3%−0.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.63 | — | — |
| Sep 2027 | −$0.62 | — | — |
| Jun 2027 | −$0.62 | — | — |
| Mar 2027 | −$0.63 | — | — |
| Dec 2026 | −$0.50 | — | — |
| Nov 2026 | −$0.50 | — | — |
| Aug 2026 | −$0.48 | −$0.53 | −10.5% |
| May 2026 | −$0.42 | −$0.50 | −19.0% |
| Mar 2026 | −$0.48 | −$0.34 | +29.2% |
| Nov 2025 | −$0.44 | −$0.49 | −11.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Mar 2020 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.63 | — | — | $4.6M | — | — | — |
| Sep 2027 | −$0.62 | — | — | $4.6M | — | — | — |
| Jun 2027 | −$0.62 | — | — | $4.6M | — | — | — |
| Mar 2027 | −$0.63 | — | — | $4.6M | — | — | — |
| Dec 2026 | −$0.50 | — | — | $13.6M | — | — | — |
| Nov 17, 2026 | −$0.50 | — | — | $12.5M | — | — | — |
| Aug 18, 2026 | −$0.48 | −$0.53 | −10.5% | $11.9M | $11.9M | −0.2% | −1.7% |
| May 12, 2026 | −$0.42 | −$0.50 | −19.0% | $9.8M | $8.8M | −10.3% | −1.3% |
| Mar 5, 2026 | −$0.48 | −$0.34 | +29.2% | $11.3M | $22.3M | +98.2% | −0.3% |
| Nov 17, 2025 | −$0.44 | −$0.49 | −11.5% | $10.7M | $6.1M | −43.3% | −7.2% |
| Aug 13, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 18, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 17, 2023 | |||||||
| May 16, 2023 | |||||||
| Mar 21, 2023 | |||||||
| Nov 17, 2022 | |||||||
| Aug 9, 2022 | |||||||
| Jun 2, 2022 | |||||||
| Mar 23, 2022 | |||||||
| Nov 16, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 18, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Dec 2, 2020 | |||||||
| Sep 3, 2020 | |||||||
| Jun 8, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Mar 6, 2020 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |